Hjem › Post-COVID-tilstander (lang-COVID) › Texas › Dallas
Kliniske studier for Post-COVID-tilstander (lang-COVID) i Dallas, TX
5 studier for Post-COVID-tilstander (lang-COVID) søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RekruttererFase 3
- Research Site, Dallas
A Study of COVID-19 Vaccine(s) in Children and Adults
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
- Cedar Health Research, Dallas
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekruttererFase 3
- Zenos Clinical Research, Dallas
- Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
- Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
- og 1 flere
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekruttererFase 3
- Zenos Clinical Research, Dallas
- Southwest Family Medicine Associates, Dallas
- Southwest Mind and Body Care, Dallas
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RekruttererFase 3
- UT Southwestern Medical Center, Dallas
Post-COVID-tilstander (lang-COVID)-studier i andre byer
- New York City, NY15 studier
- Houston, TX13 studier
- Boston, MA13 studier
- Baltimore, MD12 studier
- Chicago, IL11 studier
- Washington, DC10 studier
- San Francisco, CA8 studier
- Durham, NC8 studier
- Atlanta, GA8 studier
- San Diego, CA7 studier
- Los Angeles, CA6 studier
- Pittsburgh, PA6 studier
Andre studier i Dallas
- Brystkreft55 studier
- Ikke-småcellet lungekreft52 studier
- Metastatisk kreft42 studier
- Hjertesvikt42 studier
- Kreft (alle typer)37 studier
- Prostatakreft36 studier
- Kolorektal kreft33 studier
- Fedme30 studier
- Eggstokkreft28 studier
- Lungekreft27 studier
- Blærekreft27 studier
- Endometriekreft24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.